SPONSOR
University Hospital, Geneva
Total Trials
9
Recruiting
9
Phases
Phase 1
Conditions studied: Lung CancerOrganoidCommunicationAnxietyChronic Subdural HematomasCerebral Compression Due to InjuryCoronary Artery DiseaseDiffuse Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)Vestibular Schwannoma
University Hospital, Geneva is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Lung Cancer, Organoid, Communication, Anxiety.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital, Geneva
How many clinical trials has University Hospital, Geneva sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by University Hospital, Geneva, of which 9 are actively recruiting participants. These trials cover conditions including Lung Cancer, Organoid, Communication. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital, Geneva research focus on?
University Hospital, Geneva clinical trials span Lung Cancer, Organoid, Communication, Anxiety, Chronic Subdural Hematomas, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital, Geneva clinical trial?
To participate in a University Hospital, Geneva trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Geneva trials with current recruitment status updated daily.
Clinical Trials by University Hospital, Geneva
NCT03979170
Recruiting
Patient-derived Organoids of Lung Cancer to Test Drug Response
Lung Cancer
NCT07137377
Recruiting
Assessing the Impact of Therapeutic Communication on Patients' Anxiety During Elective Cesarean Sections
Communication
NCT06163547
Recruiting
Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM)
Chronic Subdural Hematomas
NCT06710210
Recruiting
Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
Coronary Artery Disease
NCT05641441
Recruiting
Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
Vestibular Schwannoma
NCT07506356
Recruiting
Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors
Diabete Type 2
NCT04419740
Recruiting
Impact of a Mindfulness Intervention on Infertile Women Undergoing Assisted Reproductive Technique Treatments
Infertility, Female
NCT05066412 Phase 1
Recruiting
Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC
Hematologic Malignancy
NCT07173127
Recruiting
The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters
Uterine Fibroid
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology